Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely developed TPD procedures. With this evaluate, we center on the two preclinical experiments and clinical trials to deliver a comprehensive summary of the security and medical usefulness of PROTACs and MGDs in hematologic malignancies over the past https://edsgerl418cim2.jasperwiki.com/user